Raymond James & Associates Evolus, Inc. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$3.53 - $12.21 $102,433 - $354,309	-29,018 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$11.58 - $17.37 $3,045 - $4,568	-263 Reduced 0.9%	29,018 $353,000
Q3 2019 Nov 07, 2019	BUY	$13.91 - $19.87 $167,559 - $239,354	12,046 Added 69.89%	29,281 $457,000
Q2 2019 Aug 06, 2019	BUY	$13.19 - $28.36 $227,329 - $488,784	17,235 New	17,235 $252,000
Q3 2018 Nov 14, 2018	SELL	$17.31 - $29.82 $202,198 - $348,327	-11,681 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.85 - $38.49 $80,014 - $449,601	11,681 New	11,681 $327,000

169

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $768M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.